- Home
- IDYA vs PRDO Comparison
IDYA vs PRDO Comparison
Compare IDYA & PRDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- PRDO
- Stock Information
- Founded
- IDYA 2015
- PRDO 1994
- Country
- IDYA United States
- PRDO United States
- Employees
- IDYA N/A
- PRDO N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- PRDO Other Consumer Services
- Sector
- IDYA Health Care
- PRDO Real Estate
- Exchange
- IDYA Nasdaq
- PRDO Nasdaq
- Market Cap
- IDYA 2.3B
- PRDO 2.4B
- IPO Year
- IDYA 2019
- PRDO N/A
- Fundamental
- Price
- IDYA $26.88
- PRDO $35.10
- Analyst Decision
- IDYA Buy
- PRDO Buy
- Analyst Count
- IDYA 15
- PRDO 1
- Target Price
- IDYA $47.92
- PRDO $42.00
- AVG Volume (30 Days)
- IDYA 1.2M
- PRDO 527.0K
- Earning Date
- IDYA 11-03-2025
- PRDO 11-11-2025
- Dividend Yield
- IDYA N/A
- PRDO 1.71%
- EPS Growth
- IDYA N/A
- PRDO 12.96
- EPS
- IDYA N/A
- PRDO 2.30
- Revenue
- IDYA $7,000,000.00
- PRDO $768,844,000.00
- Revenue This Year
- IDYA $63.41
- PRDO $25.27
- Revenue Next Year
- IDYA $305.49
- PRDO $4.01
- P/E Ratio
- IDYA N/A
- PRDO $15.22
- Revenue Growth
- IDYA N/A
- PRDO 15.99
- 52 Week Low
- IDYA $13.45
- PRDO $20.55
- 52 Week High
- IDYA $32.67
- PRDO $38.03
- Technical
- Relative Strength Index (RSI)
- IDYA 59.69
- PRDO 46.83
- Support Level
- IDYA $26.77
- PRDO $34.29
- Resistance Level
- IDYA $28.41
- PRDO $37.62
- Average True Range (ATR)
- IDYA 0.92
- PRDO 0.86
- MACD
- IDYA 0.04
- PRDO -0.34
- Stochastic Oscillator
- IDYA 59.24
- PRDO 13.25
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
About PRDO Perdoceo Education Corporation
Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the company's revenue comes from the Colorado Technical University segment.